Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro

Journal of Neuroscience Research
Andreea C PopescuJames H Eubanks

Abstract

Rett syndrome is a pediatric neurological condition that affects primarily girls. Approximately 30% of Rett syndrome cases arise from point mutations that introduce a premature stop codon into the MECP2 gene. Several studies have now shown that certain aminoglycosides can facilitate read-through of some types of nonsense mutations in a context-dependent manner and allow the generation of a full-length protein. It remains mostly unclear whether different nonsense mutations of MECP2 will be responsive to aminoglycoside treatment. In this study, we tested whether the common premature terminating mutations of MECP2 seen in Rett syndrome cases can be partially suppressed by aminoglycoside administration. Our results show that aminoglycosides allow different mutant forms of MECP2 to be overcome in transiently transfected HEK293 cells, but with differing levels of efficiency. In addition, we also show that aminoglycosides increased the prevalence of full-length MeCP2 protein in a dose-dependent manner in a lymphocyte cell line derived from a Rett syndrome girl with the R255X mutation. This study helps to establish the "proof of principle" that some nonsense mutations causing Rett syndrome can be at least partially suppressed by drug t...Continue Reading

References

Nov 14, 1997·Nature Medicine·D M BedwellE J Sorscher
Aug 17, 1999·The Journal of Clinical Investigation·E R Barton-DavisH L Sweeney
Jun 20, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Kim M Keeling, David M Bedwell
Apr 8, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sandra LuikenhuisRudolf Jaenisch
Sep 8, 2004·Human Molecular Genetics·Ann L CollinsHuda Y Zoghbi
Oct 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chih-Hung LaiRichard A Gatti
Mar 17, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ming DuDavid M Bedwell
May 19, 2006·Journal of Thrombosis and Haemostasis : JTH·M PinottiUNKNOWN International Factor VII Deficiency Study Group
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Emanuela GiacomettiRudolf Jaenisch
Apr 24, 2007·Nature·Ellen M WelchH Lee Sweeney
May 9, 2007·Epigenetics : Official Journal of the DNA Methylation Society·Raman P NagarajanJanine M LaSalle
Jan 5, 2008·Journal of Child Neurology·Alan K PercyPatrick MacLeod
Feb 5, 2009·Pediatric Research·Cornelia BrendelPeter Huppke

❮ Previous
Next ❯

Citations

Dec 2, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Cornelia BrendelPeter Huppke
Mar 13, 2014·Neuromolecular Medicine·Vichithra R B Liyanage, Mojgan Rastegar
Dec 9, 2014·Mutation Research. Reviews in Mutation Research·Jake N Miller, David A Pearce
Oct 23, 2012·Trends in Molecular Medicine·Laure BidouOlivier Namy
Sep 4, 2012·Neuropharmacology·Laura RicceriGiovanni Laviola
Jul 24, 2012·Pharmacology & Therapeutics·Hui-Ling Rose Lee, Joseph P Dougherty
Sep 17, 2013·Annals of Neurology·Jonathan D Picker, Christopher A Walsh
Feb 16, 2012·Human Mutation·Rocío Sánchez-AlcudiaLourdes R Desviat
Mar 15, 2015·Frontiers in Cellular Neuroscience·Hansen WangLaurie C Doering
Apr 11, 2017·The Journal of Clinical Investigation·Janine M LamonicaZhaolan Zhou
Sep 16, 2011·The Biochemical Journal·Kamal K E GadallaStuart R Cobb
Mar 2, 2019·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Neeti Vashi, Monica J Justice

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.